Top Pharmaceuticals companies in Switzerland by Net Income
Switzerland
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 14.85 B
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
| 2 |
USD 13.66 B
|
Dec. 31, 2023 | USD 310.22 | 0.71% |
|
Switzerland |
|
| 3 |
USD 974.00 M
|
Dec. 31, 2023 | USD 82.92 | 0.05% |
|
Switzerland |
|
| 4 |
USD 776.78 M
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
| 5 |
USD 292.27 M
|
Dec. 31, 2023 | USD 129.81 | 2.09% |
|
Switzerland |
|
| 6 |
USD 216.17 M
|
Dec. 31, 2023 | USD 73.83 | -0.24% |
|
Switzerland |
|
| 7 |
USD 206.19 M
|
Dec. 31, 2023 | USD 84.29 | 1.29% |
|
Switzerland |
|
| 8 |
USD 156.87 M
|
Dec. 31, 2023 | USD 244.50 | 0.95% |
|
Switzerland |
|
| 9 |
USD 133.95 M
|
Dec. 31, 2023 | USD 1.04 K | -2.38% |
|
Switzerland |
|
| 10 |
USD 132.86 M
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
| 11 |
USD 97.73 M
|
Dec. 31, 2023 | USD 19.40 | 2.88% |
|
Switzerland |
|
| 12 |
USD 93.69 M
|
Dec. 31, 2023 | USD 85.22 | -0.53% |
|
Switzerland |
|
| 13 |
USD 89.37 M
|
March 31, 2024 | USD 229.49 | 0.50% |
|
Switzerland |
|
| 14 |
USD 86.87 M
|
March 31, 2024 | USD 355.46 | -1.48% |
|
Switzerland |
|
| 15 |
USD 79.34 M
|
Dec. 31, 2023 | USD 140.65 | 0.97% |
|
Switzerland |
|
| 16 |
USD 77.00 M
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
| 17 |
USD 65.07 M
|
Dec. 31, 2023 | USD 14.50 | 8.00% |
|
Switzerland |
|
| 18 |
USD 52.28 M
|
Dec. 31, 2023 | USD 119.40 | 0.87% |
|
Switzerland |
|
| 19 |
USD 31.25 M
|
Dec. 31, 2023 | USD 81.72 | -0.97% |
|
Switzerland |
|
| 20 |
USD 26.39 M
|
Dec. 31, 2023 | USD 1.16 K | 0.97% |
|
Switzerland |
|
| 21 |
USD 17.99 M
|
Dec. 31, 2023 | USD 165.41 | 0.50% |
|
Switzerland |
|
| 22 |
USD 14.19 M
|
Dec. 31, 2023 | USD 56.52 | -0.28% |
|
Switzerland |
|
| 23 |
USD 12.41 M
|
Dec. 31, 2023 | USD 44.53 | -0.85% |
|
Switzerland |
|
| 24 |
USD 735.21 K
|
Dec. 31, 2023 | USD 73.39 | 4.71% |
|
Switzerland |
|
| 25 |
USD 356.32 K
|
Dec. 31, 2023 | USD 11.09 | -3.14% |
|
Switzerland |
|
| 26 |
USD -12.17 M
|
Dec. 31, 2023 | USD 2.03 | -1.93% |
|
Switzerland |
|
| 27 |
USD -12.54 M
|
Dec. 31, 2023 | USD 7.39 | -3.40% |
|
Switzerland |
|
| 28 |
USD -16.30 M
|
Dec. 31, 2023 | USD 24.15 | -4.07% |
|
Switzerland |
|
| 29 |
USD -36.01 M
|
Dec. 31, 2023 | USD 46.50 | 2.74% |
|
Switzerland |
|
| 30 |
USD -56.78 M
|
Dec. 31, 2023 | USD 27.99 | -3.47% |
|
Switzerland |
|
| 31 |
USD -64.41 M
|
Dec. 31, 2023 | USD 2.61 | NA |
|
Switzerland |
|
| 32 |
USD -73.62 M
|
Dec. 31, 2023 | USD 5.48 | 3.60% |
|
Switzerland |
|
| 33 |
USD -105.47 M
|
Dec. 31, 2023 | USD 22.44 | 0.27% |
|
Switzerland |
|
| 34 |
USD -153.61 M
|
Dec. 31, 2023 | USD 38.36 | -1.26% |
|
Switzerland |
|
| 35 |
USD -240.05 M
|
Dec. 31, 2023 | USD 1.71 | -0.58% |
|
Switzerland |
|
| 36 |
USD -719.64 M
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
Frequently Asked Questions
-
Which Pharmaceuticals company in Switzerland has the highest Net Income ?
The Pharmaceuticals company in Switzerland with the highest Net Income is Novartis AG (Swiss Stock Exchange: NOVN.SW) at USD 14.85 B.
-
Which Pharmaceuticals company in Switzerland has the lowest Net Income ?
The Pharmaceuticals company in Switzerland with the lowest Net Income is DSM-Firmenich AG (Amsterdam Stock Exchange: DSFIR.AS) at USD -719.64 M.
-
What are the top 10 Pharmaceuticals companies in Switzerland by Net Income ?
The top 10 Pharmaceuticals companies in Switzerland by Net Income are Novartis AG, Roche Holding AG, Alcon Inc., Lonza Group AG, Straumann Holding AG, DKSH Holding AG, Galenica AG, Tecan Group AG, Siegfried Holding AG and Bachem Holding AG.
-
What are the bottom 10 Pharmaceuticals companies in Switzerland by Net Income ?
The bottom 10 Pharmaceuticals companies in Switzerland by Net Income are DSM-Firmenich AG, ADC Therapeutics SA, CRISPR Therapeutics AG, Oculis Holding AG, Molecular Partners AG, AC Immune SA, PolyPeptide Group AG, MoonLake Immunotherapeutics, Kuros Biosciences AG and Addex Therapeutics Ltd.